HBV Policy & Advocacy
HIV Glasgow: French Study Reveals Growing Complexity of Medical Needs as People with HIV Age
- Details
- Category: HIV-Related Conditions
- Published on Friday, 28 October 2016 00:00
- Written by Keith Alcorn
The complexity of the needs of people living with HIV will continue to increase as the population ages, and clinicians need to go beyond thinking about co-morbidities to consider multi-morbidities -- clusters of medical conditions that complicate one another -- when caring for these people, Edouard Battegay from the University Hospital Zurich told attendees at the International Congress on Drug Therapy in HIV Infection (HIV Glasgow) this week.
HIV Glasgow: Dolutegravir and Central Nervous System Side-Effects -- Abacavir, Older Age Increase the Risk
- Details
- Category: Approved HIV Drugs
- Published on Friday, 28 October 2016 00:00
- Written by Keith Alcorn
Insomnia, dizziness, headache, and other central nervous system (CNS) side effects are occurring more frequently with everyday use of dolutegravir than clinical trials had suggested, and are most likely to occur among women, people over age 60, and people starting abacavir at the same time, a German research group reported at the International Congress on Drug Therapy in HIV Infection (HIV Glasgow) this week.
U.S. Government Releases Updated Viral Hepatitis Action Plan
- Details
- Category: HBV Policy & Advocacy
- Published on Tuesday, 08 April 2014 00:00
- Written by HIVandHepatitis.com
On April 3 the federal government released its latest 3-year update to the Action Plan for the Prevention, Care and Treatment of Viral Hepatitis (initially launched in 2011), which provides a framework for strengthening the nation's response to hepatitis B and C.
HIV Glasgow: New $90-$90-$90 Target Needed for Global Viral Hepatitis, HIV, and TB Treatment
- Details
- Category: Drug Pricing & Patents
- Published on Monday, 24 October 2016 00:00
- Written by Keith Alcorn
The costs of making drugs to treat viral hepatitis, HIV, and tuberculosis (TB) are now so low that each disease could be treated for less than $90, Andrew Hill of St. Stephen’s AIDS Trust said at the opening plenary of the International Congress of Drug Therapy in HIV Infection this week in Glasgow.
DHHS Releases Viral Hepatitis Action Plan
- Details
- Category: HBV Policy & Advocacy
- Published on Friday, 13 May 2011 15:41
- Written by DHHS
New DHHS report details plan for prevention, care, and treatment of hepatitis B and C. 
Web Design and Development by